HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mohammed M Alanazi Selected Research

SB-332235

1/2022CXCR2 antagonist SB332235 mitigates deficits in social behavior and dysregulation of Th1/Th22 and T regulatory cell-related transcription factor signaling in male BTBR T+ Itpr3tf/J mouse model of autism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mohammed M Alanazi Research Topics

Disease

10Neoplasms (Cancer)
08/2022 - 01/2019
3Inflammation (Inflammations)
06/2022 - 08/2021
2Autistic Disorder (Autism)
05/2022 - 01/2022
2Breast Neoplasms (Breast Cancer)
01/2021 - 06/2019
1Acute Lung Injury
06/2022
1Alzheimer Disease (Alzheimer's Disease)
01/2022
1Hematologic Neoplasms (Hematological Malignancy)
08/2021
1COVID-19
05/2021
1Cardiomegaly (Heart Hypertrophy)
01/2021
1Hypertension (High Blood Pressure)
01/2021
1Autism Spectrum Disorder
06/2020
1Hepatocellular Carcinoma (Hepatoma)
01/2020
1Thyroid Neoplasms (Thyroid Cancer)
01/2020
1Renal Cell Carcinoma (Grawitz Tumor)
01/2020
1Autoimmune Diseases (Autoimmune Disease)
01/2020
1Experimental Arthritis
01/2020
1Rheumatoid Arthritis
01/2020
1Acute Kidney Injury (Acute Renal Failure)
03/2019
1Sepsis (Septicemia)
03/2019

Drug/Important Bio-Agent (IBA)

5Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
08/2022 - 06/2019
3AntioxidantsIBA
04/2022 - 01/2021
2Doxorubicin (Adriamycin)FDA LinkGeneric
04/2022 - 08/2021
2Transcription Factors (Transcription Factor)IBA
01/2022 - 06/2020
2CytokinesIBA
06/2020 - 03/2019
2Acetazolamide (Diamox)FDA LinkGeneric
11/2019 - 01/2019
2Protein Isoforms (Isoforms)IBA
11/2019 - 01/2019
1apremilastIBA
06/2022
1phthalic acid (phthalate)IBA
05/2022
1geraniol (nerol)IBA
04/2022
1Chalcone (Benzalacetophenone)IBA
01/2022
1SB-332235IBA
01/2022
1CoumarinsIBA
01/2022
1AcetylcholinesteraseIBA
01/2022
1Antineoplastic Agents (Antineoplastics)IBA
12/2021
1Cytotoxins (Cytolysins)IBA
12/2021
1AnthracyclinesIBA
08/2021
1Anti-Bacterial Agents (Antibiotics)IBA
08/2021
1Diosmin (Daflon)IBA
08/2021
1VaccinesIBA
05/2021
1Biological ProductsIBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1Acetylcarnitine (Alcar)IBA
01/2021
1Myosin Heavy Chains (Myosin Heavy Chain)IBA
01/2021
1Carnitine (L-Carnitine)FDA LinkGeneric
01/2021
1Insulin (Novolin)FDA Link
01/2021
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
06/2020
1N- (1- (3- (4- ethoxyphenyl)- 4- oxo- 3,4- dihydropyrido(2,3- d)pyrimidin- 2- yl)ethyl)- N- pyridin- 3- ylmethyl- 2- (4- trifluoromethoxyphenyl)acetamideIBA
01/2020
1CXCR3 ReceptorsIBA
01/2020
1Sorafenib (BAY 43-9006)FDA Link
01/2020
1IodineIBA
01/2020
1Chemokine ReceptorsIBA
01/2020
1SLC-0111IBA
11/2019
1Pharmaceutical PreparationsIBA
06/2019
1tyrosine receptor (receptor, tyrosine)IBA
06/2019
1Lapatinib (GW572016)FDA Link
06/2019
1Phosphotransferases (Kinase)IBA
06/2019
1GSK 1363089IBA
06/2019
1Syk KinaseIBA
03/2019
1Urea (Carbamide)FDA LinkGeneric
03/2019
1NitrogenIBA
03/2019
1Peroxidase (Myeloperoxidase)IBA
03/2019
1CreatinineIBA
03/2019
13-nitrotyrosineIBA
03/2019
1Carbonic Anhydrases (Carbonic Anhydrase)IBA
01/2019
1BenzenesulfonamidesIBA
01/2019

Therapy/Procedure

1Therapeutics
06/2019